Townsend Richard Nolan, CEO of Lexeo Therapeutics ($LXEO), sold shares on the open market seven times over the past year for a total of $213,758. His most recent sale occurred on February 18, 2026. These transactions rank 8,280th among 11,678 insiders in our database, where the average sale totals $8.6 million across about six trades per insider. Nolan made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 2623 | $2.64 | 395,106.0000 | 72,987,327 | 0.67% | 0.00% |
| Feb. 18, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 10173 | $6.38 | 392,483.0000 | 72,987,327 | 2.53% | 0.01% |
| Feb. 4, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 161665 | $0.00 | 402,656.0000 | 72,987,327 | 67.08% | 0.22% |
| Feb. 4, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Stock Option (right to buy) | 646665 | $0.00 | 646,665.0000 | 72,987,327 | 9999.99% | 0.89% |
| Nov. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 1127 | $9.27 | 240,991.0000 | 72,987,327 | 0.47% | 0.00% |
| Oct. 15, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 33000 | $0.00 | 255,251.0000 | 33,196,997 | 14.85% | 0.10% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 148 | $9.56 | 242,118.0000 | 33,196,997 | 0.06% | 0.00% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 12985 | $8.94 | 242,266.0000 | 33,196,997 | 5.09% | 0.04% |
| Sept. 12, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 2193 | $2.64 | 222,251.0000 | 33,196,997 | 1.00% | 0.01% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 1115 | $4.67 | 220,058.0000 | 33,196,997 | 0.50% | 0.00% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 2735 | $4.67 | 220,058.0000 | 33,196,997 | 1.23% | 0.01% |
| May 16, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 1074 | $2.77 | 221,173.0000 | 33,196,997 | 0.48% | 0.00% |
| March 14, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 2128 | $2.61 | 222,247.0000 | 0 | 0.97% | 0.00% |
| Feb. 19, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 4326 | $4.41 | 220,119.0000 | 0 | 1.93% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Stock Option (right to buy) | 207500 | $0.00 | 207,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 103750 | $0.00 | 224,445.0000 | 0 | 85.96% | 0.00% |
| Dec. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 2500 | $2.33 | 123,195.0000 | 0 | 2.07% | 0.00% |
| Dec. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 2500 | $8.20 | 120,695.0000 | 0 | 2.03% | 0.00% |
| Dec. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 2500 | $0.00 | 118,655.0000 | 0 | 2.06% | 0.00% |
| Nov. 11, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 2500 | $7.82 | 120,695.0000 | 0 | 2.03% | 0.00% |
| Nov. 11, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 2500 | $0.00 | 121,155.0000 | 0 | 2.02% | 0.00% |
| Nov. 11, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 2500 | $2.33 | 123,195.0000 | 0 | 2.07% | 0.00% |
| Oct. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 5000 | $2.33 | 125,695.0000 | 0 | 4.14% | 0.00% |
| Oct. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 123,655.0000 | 0 | 3.89% | 0.00% |
| Oct. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 5000 | $8.10 | 120,695.0000 | 0 | 3.98% | 0.00% |
| Sept. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 5000 | $10.65 | 120,695.0000 | 0 | 3.98% | 0.00% |
| Sept. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 128,655.0000 | 0 | 3.74% | 0.00% |
| Sept. 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 5000 | $2.33 | 125,695.0000 | 0 | 4.14% | 0.00% |
| Aug. 12, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 5000 | $2.33 | 125,695.0000 | 0 | 4.14% | 0.00% |
| Aug. 12, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 5000 | $11.53 | 120,695.0000 | 0 | 3.98% | 0.00% |
| Aug. 12, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 133,655.0000 | 0 | 3.61% | 0.00% |
| July 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 3347 | $16.85 | 148,726.0000 | 0 | 2.20% | 0.00% |
| July 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 138,655.0000 | 0 | 3.48% | 0.00% |
| July 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 5000 | $2.33 | 175,695.0000 | 0 | 2.93% | 0.00% |
| July 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 23622 | $16.45 | 152,073.0000 | 0 | 13.44% | 0.00% |
| July 11, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 100 | $19.06 | 120,695.0000 | 0 | 0.08% | 0.00% |
| July 11, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 27931 | $17.06 | 120,795.0000 | 0 | 18.78% | 0.00% |
| June 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 5000 | $2.33 | 175,695.0000 | 0 | 2.93% | 0.00% |
| June 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 2038 | $18.18 | 170,695.0000 | 0 | 1.18% | 0.00% |
| June 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 143,655.0000 | 0 | 3.36% | 0.00% |
| June 10, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 2962 | $17.29 | 172,733.0000 | 0 | 1.69% | 0.00% |
| May 13, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Stock Option (Right to Buy) | 5000 | $2.33 | 148,655.0000 | 0 | 3.25% | 0.00% |
| May 13, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | S | Common Stock | 5000 | $13.22 | 170,695.0000 | 0 | 2.85% | 0.00% |
| May 13, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | M | Common Stock | 5000 | $2.33 | 175,695.0000 | 0 | 2.93% | 0.00% |
| Jan. 5, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Common Stock | 43750 | $0.00 | 170,695.0000 | 0 | 34.46% | 0.00% |
| Jan. 5, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Townsend Richard Nolan | Chief Executive Officer | A | Stock Option (Right to Buy) | 262500 | $0.00 | 262,500.0000 | 0 | 9999.99% | 0.00% |